Package 50228-144-05

{"route": ["ORAL"], "spl_id": "1105c206-a0be-4ea0-a6e3-1371ac2df153", "openfda": {"upc": ["0350228145909", "0350228145305", "0350228144902", "0350228144308"], "unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["05f82eca-cc87-4580-acd7-e6491c651881"], "manufacturer_name": ["ScieGen Pharmaceuticals,Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-144-05)", "package_ndc": "50228-144-05", "marketing_start_date": "20170412"}, {"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-144-30)", "package_ndc": "50228-144-30", "marketing_start_date": "20170412"}, {"sample": false, "description": "90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50228-144-90)", "package_ndc": "50228-144-90", "marketing_start_date": "20170412"}], "brand_name": "Bupropion Hydrochloride (XL)", "product_id": "50228-144_1105c206-a0be-4ea0-a6e3-1371ac2df153", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "50228-144", "generic_name": "bupropion hydrochloride", "labeler_name": "ScieGen Pharmaceuticals,Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "(XL)", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA207479", "marketing_category": "ANDA", "marketing_start_date": "20170412", "listing_expiration_date": "20271231"}